An alternative hypothesis for the enrichment of DNMT3A mutations is clonal hematopoiesis of unknown potential, a process in which somatic mutations in hematopoietic stem cells lead to the outgrowth of distinct subclones that have been associated with cancer [64–66]; we provide evidence for this hypothesis in S3 Fig. Here, DNMT3A is linked to cancer.